Document is current
Any future updates will be listed below
-
Authors
Del Campo, Judith
Pizzorno, Andres http://orcid.org/0000-0002-0918-6804
Djebali, Sophia http://orcid.org/0000-0002-0567-5387
Bouley, Julien
Haller, Marjorie
Pérez-Vargas, Jimena
Lina, Bruno
Boivin, Guy
Hamelin, Marie-Eve
Nicolas, Florence
Le Vert, Alexandre
Leverrier, Yann http://orcid.org/0000-0002-4227-5446
Rosa-Calatrava, Manuel
Marvel, Jacqueline http://orcid.org/0000-0001-6241-459X
Hill, Fergal
-
Funding
Funding for this research was provided by:
ARN Funded Project "OPTIVAC" DS0404
- License Information
-
More Information
Article History
Received: 27 March 2018
Accepted: 21 December 2018
First Online: 23 January 2019
Competing interests
: J.d.C. and F.H. are named as inventors on a family of patents/patent applications “Influenza Nucleoprotein vaccines” (WO 2014/090905, WO 2014/147087), and both are shareholders and employees of OSIVAX. The remaining authors declare no competing interests.
